CVACCVAC seems to me to be between the support in the 3.10 area and the resistance in the 3.65 area,
the breakout of one of these two levels will determine the new direction in my opinion,
if it exceeds 3.65 it could quickly move to the 4.3 area
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.207 CHF
−236.81 M CHF
48.93 M CHF
93.63 M
About CureVac N.V.
Sector
CEO
Alexander Zehnder
Headquarters
Tübingen
Website
Founded
2020
ISIN
NL0015436031
FIGI
BBG00WRCCGP7
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Holding PowerThis is one of the ways to make a profit in the financial market. This way is by using HOLD POWER. Hold power is when you believe that a company has the strength to last for a long time. With that, you will hold until you reach the targeted profit. You have set your mentality that, 'I will only lose
CVAC, will pull a NVAX-type surge (x3) soon! CVAC has been under a heavy bear weight this past few months.
But it seems like that will change soon. Based on our weekly data metrics a big shift is currently transpiring. The first long term up- shift in almost 12 months has been registered. This is a massive change in trend. We got a break in
CVAC Buy TF H1 TP = 10.21On the hourly chart the trend started on July 28 (linear regression channel).
There is a high probability of profit taking. Possible take profit level is 10.21
But we should not forget about SL = 7.99
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am ve
CVAC - Trade Opportunity Looking through charts, CVAC caught my eye for some potential trade opportunities.
Firstly lets look at the candle close of Today 08/01/23
-> We are currently testing this RED Resistance Arrow Line pointing down
-> The candle has a lower wick, indicating some buying pressure
->However, the candle b
CVAC, BNTX & MRNA comparisonCureVac N.V. (CVAC) has filed a patent infringement lawsuit in Germany against BioNTech to assert the company's intellectual property rights which contributed to COVID-19 vaccine development. The company said the CureVac intellectual property portfolio protects multiple inventions that are considere
CureVac N.V bullishCureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA
Curevac is completely oversold I see that this stock has been very hit lately, the pattern I see tells me that a reversal may be close and that it is completely oversold.
I see that it can return maximum to about 40 dollars in the following days or weeks.
CVAC Long Position Idea with Potential 45% gainLooking at the chart that gapped down. CVAC has a history of filling the gap. Expecting a gap fill with a risk/reward ratio of 1.57
I am not a financial advisor. Do your own research
Buy at 64.30
Sell at 93.70
Stop Loss 44
First Target 75
Second Target 89-94
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 5CV is 2.498 CHF — it has decreased by −1.69% in the past 24 hours. Watch CUREVAC NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange CUREVAC NV stocks are traded under the ticker 5CV.
5CV stock has fallen by −1.49% compared to the previous week, the month change is a −1.96% fall, over the last year CUREVAC NV has showed a −49.42% decrease.
We've gathered analysts' opinions on CUREVAC NV future price: according to them, 5CV price has a max estimate of 13.60 CHF and a min estimate of 2.21 CHF. Watch 5CV chart and read a more detailed CUREVAC NV stock forecast: see what analysts think of CUREVAC NV and suggest that you do with its stocks.
5CV stock is 3.19% volatile and has beta coefficient of 1.19. Track CUREVAC NV stock price on the chart and check out the list of the most volatile stocks — is CUREVAC NV there?
Today CUREVAC NV has the market capitalization of 551.40 M, it has increased by 6.19% over the last week.
Yes, you can track CUREVAC NV financials in yearly and quarterly reports right on TradingView.
CUREVAC NV is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
5CV earnings for the last quarter are −0.31 CHF per share, whereas the estimation was −0.27 CHF resulting in a −14.00% surprise. The estimated earnings for the next quarter are 1.33 CHF per share. See more details about CUREVAC NV earnings.
CUREVAC NV revenue for the last quarter amounts to 13.87 M CHF, despite the estimated figure of 7.74 M CHF. In the next quarter, revenue is expected to reach 3.16 M CHF.
5CV net income for the last quarter is −70.21 M CHF, while the quarter before that showed −69.08 M CHF of net income which accounts for −1.64% change. Track more CUREVAC NV financial stats to get the full picture.
No, 5CV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 1.17 K employees. See our rating of the largest employees — is CUREVAC NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CUREVAC NV EBITDA is −264.71 M CHF, and current EBITDA margin is −473.93%. See more stats in CUREVAC NV financial statements.
Like other stocks, 5CV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CUREVAC NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CUREVAC NV technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CUREVAC NV stock shows the sell signal. See more of CUREVAC NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.